Research, News & Discoveries

Vanderbilt researchers’ partnership with Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt University’s innovative life science research, has added an effort to develop therapeutics for a rare form of epilepsy. This is the fourth drug discovery and development program supported through the Ancora-Vanderbilt collaboration. … Read More

In recognition of Roger Chalkley, retired senior associate dean for biomedical research education and training, Dr. Tom Daniel, a former Vanderbilt professor, biotechnology R&D leader, and venture investor, has established the Dr. Roger Chalkley Critical Need Fund to support biomedical graduate students who encounter unanticipated financial challenges. Read More

Antentor Hinton Jr., assistant professor of molecular physiology and biophysics at the School of Medicine Basic Sciences, has been awarded a grant from Chan Zuckerberg Initiative’s Science Diversity Leadership program. The $1.5 million, five-year grant will support his work on “finding organelle… Read More

In this issue of the 35th volume of Chemical Research in Toxicology (CRT), we share a special collection of science that celebrates the tremendous advances in this period at the intersection of chemistry and toxicology. Throughout the year, every issue of the Journal has borne a 35-year anniversary symbol to… Read More

Vanderbilt University faculty members have been elected this year to membership in the National Academy of Medicine, a prestigious, non-governmental organization that advises the nation and the world on important aspects of medical science, health care and public health. Monteggia was recruited to Vanderbilt in 2018 to… Read More

In the mammalian brain, the chief inhibitory neurotransmitter is called GABA. The gene SLC6A1 encodes the GABA transporter GAT1, and in Neurobiology of Disease, Felicia Mermer, Sarah Poliquin, Jing-Qiong Kang, MD, PhD, and colleagues report experiments — in silico, in vitro and in mice-o… Read More

The Quality Education for Minorities Network, in partnership with Vanderbilt University, Louisiana Tech University, North Dakota State University and Temple University researchers, has been awarded nearly $70,000 in funding from the National Science Foundation to host the Pipelines to Pathways: Humanizing Diversity in STEM Conference. The conference aims to engage… Read More

James Crowe Jr., MD, director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization, for his team’s role in developing human monoclonal antibodies and vaccine candidates against COVID-19. The award, which was announced Oct. 6,… Read More

Vanderbilt University Medical Center has been awarded a nearly $8 million grant from the National Institutes of Health to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms. VUMC currently has two BSL3 labs, but they are small, outdated and… Read More

Vanderbilt University Medical Center has received a five-year, $5 million grant from the National Cancer Institute to study precancerous lesions and early cancers in the colon, with the goal of developing new ways to prevent colorectal cancer, the nation’s second leading cancer killer. Robert Coffey, MD, Martha Shrubsole, PhD, and Ken… Read More